In view of PI3K inhibitors were determined that could reverse TKIs resistance in tumor 73, and activated AKT promoting TKIs resistance in RCC 74, we speculate that MIR503HG-KO cells will be more sensitive to those TKIs than control cells. The gene discussed is AKT1; the disease is renal cell carcinoma.